Ivo Sulovsky

Ivo Sulovsky currently serves as the Head of Portfolio Strategy and Planning at Orphalan, a position held since January 2024. Prior experience includes roles at Ipsen from April 2019 to December 2023, where Ivo was Vice President and General Manager, as well as Head of Endocrinology/Rare Disease Marketing in the USA. Ivo's tenure at Amgen from August 2009 to March 2019 included serving as Business Unit Director with a focus on Oncology, where leadership of a cross-functional team was pivotal for the commercialization of oncology and hematology products. Additional roles at Amgen encompassed various Head of Business Unit positions and responsibilities in sales effectiveness and key account management. Earlier in the career, Ivo worked as a Senior Project Manager at Roland Berger Strategy Consultants and held consulting positions at IMS Health and The Boston Consulting Group. Ivo holds a Master of Science degree in Commerce/Business Administration from WU (Vienna University of Economics and Business).